Koninklijke Philips N.V. operates as a health technology company in North America, Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides magnetic resonance imaging, computed tomography, advanced molecular imaging, diagnostic X-ray, and imaging components as well as integrated clinical solutions; integrated interventional systems, including interventional diagnostic and therapeutic devices; imaging products focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. The company also offers monitoring and analytics solutions; sleep and respiratory care solutions; emergency care and resuscitation, and patient management solutions; data, analytics, and actionable workflow solutions; and connected care informatics solutions. In addition, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; male grooming and beauty products and solutions; and kitchen appliances, home care, and garment care products, as well as coffee machines. Koninklijke Philips N.V. has a partnership with openDoctor to deliver an integrated radiology patient engagement platform that leverages openDoctor's real-time online appointment scheduling services as part of its patient management solution; and a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
IPO Year:
Exchange: NYSE
Website: philips.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/29/2024 | Underperform → Hold | Jefferies | |
| 5/13/2024 | Mkt Perform → Outperform | Bernstein | |
| 5/7/2024 | Underperform → Neutral | Exane BNP Paribas | |
| 4/30/2024 | Sell → Neutral | UBS | |
| 4/30/2024 | Underweight → Neutral | JP Morgan | |
| 2/7/2024 | Outperform → Underperform | Exane BNP Paribas | |
| 7/12/2023 | Buy | Goldman | |
| 1/17/2023 | Neutral → Sell | UBS | |
| 10/18/2022 | Equal-Weight | Morgan Stanley | |
| 10/14/2022 | Hold → Sell | Deutsche Bank |
SC 13D/A - KONINKLIJKE PHILIPS NV (0000313216) (Subject)
SC 13D/A - KONINKLIJKE PHILIPS NV (0000313216) (Subject)
SC 13D - KONINKLIJKE PHILIPS NV (0000313216) (Subject)
SC 13G/A - KONINKLIJKE PHILIPS NV (0000313216) (Subject)
Patient monitoring platform to deliver tools and time to help patients across 40+ care sitesRoyal Philips (NYSE:PHG, AEX: PHIA))))) a global leader in health technology and Bon Secours Mercy Health (BSMH), one of the nation's largest Catholic health systems, today announced a multi-year strategic collaboration for patient monitoring. Putting BSMH clinicians in control, the collaboration will reduce the digital burden on staff and give them more time to spend with patients.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240716028105/en/The partnership provides access to the latest Philips monitoring innovations, including a scalable
- Reuters
Royal Philips NV (NYSE:PHG) shares are trading higher on Wednesday. Italy's famous Agnelli family has increased its investment in Philips, showcasing a robust vote of confidence in the Dutch firm known for its medical devices. Through Exor NV, the family's holding company, the Agnellis now controls 17.51% of Philips, enhancing their position as the company's largest shareholder, an increase from 16.1% recorded in May. This expansion in their stake is indicative of growing trust in Philips' market prospects and management following the recent resolution of legal issues in the U.S., reported Bloomberg. Philips reached a $1.1 billion settlement in the U.S. related to the recall of its
Intuitive motorization for greater control and high-power (25 kW [1]) for state-of-the-art image quality supports complex vascular needs and a full range of clinical proceduresAutomated workflows contribute to greater flexibility and independence for clinicians, providing more time to focus on achieving the best possible outcomes for patientsAmsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA))))), a global leader in health technology, today announced the launch of Philips Image Guided Therapy Mobile C-arm System 9000 – Zenition 90 Motorized, designed to help clinicians deliver high-quality care to more patients. Philips is partnering with its customers to improve productivity. T
Sanger Heart & Vascular Institute, Atrium Health, treated the first patient with the new implantable medical device following FDA premarket approvalAmsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA))))), a global leader in health technology, today announced the first implant of the Duo Venous Stent System, an implantable medical device indicated to treat symptomatic venous outflow obstruction in patients with chronic venous insufficiency (CVI), following premarket approval (PMA) from the U.S. Food and Drug Association (FDA).
Three studies demonstrate how Philips MCOT wearable ambulatory monitoring ECG and proprietary AI models applied to ECG digital biomarkers can help to improve diagnosis, reduce readmissions, and lower costs
Koninklijke Philips N.V. (NYSE:PHG) has reportedly taken legal action against SoClean to allocate a portion of the recent $1.1 billion settlement concerning alleged injuries caused by Philips’ recalled devices. In June 2021, Philips initiated a voluntary recall notification for certain CPAP and BiPAP sleep therapy devices and ventilators related to the polyester-based polyurethane (PE-PUR) sound abatement foam in these devices that were harmful to the users. Last month, the Dutch medical technology firm reached a $1.1 billion settlement in the U.S. related to the recall of its Respironics ventilators. SoClean is known for its ozone-based cleaning systems for breathing devices, Reut
Bernstein analyst Lisa Bedell Clive upgrades Koninklijke Philips (NYSE:PHG) from Market Perform to Outperform.
- Reuters
6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)
6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)
6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)
6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)
6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)
6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)
6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)
SD - KONINKLIJKE PHILIPS NV (0000313216) (Filer)
6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)
6-K - KONINKLIJKE PHILIPS NV (0000313216) (Filer)
Nov. 21, 2024 Industry's first wide bore, high-performance helium-free [1] 1.5T MR features AI assistance at every step in the MRI workflow, with seamless integration of cloud-based AI image reading and reporting tools on the MR scanner Philips BlueSeal helium-free magnet combined with compact and lightweight design allows flexibility of installations in difficult and remote locations to improve wider access to advanced MRIPhilips' award-winning [2] AI-based SmartSpeed image reconstruction technology delivers exceptional image quality to save time and improve outcomes with up to 65% higher resolution or up to 3x faster scanning [3] Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX
Partnership continues this holiday season to encourage folks to embrace their personal growth and facial hair looks CAMBRIDGE, Mass., Nov. 13, 2024 /PRNewswire/ -- Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, is unveiling today the next phase of its ad campaign for Philips Norelco, a leading electric grooming brand, with actor and facial hair enthusiast Adam Scott. Together, Philips Norelco and Scott are debuting a new creative spot ahead of the holiday season. View here. The video features Scott – the self-proclaimed holiday season's No. 1 Facial Hair Ambassador – paying tribute to one of the world's most iconic figures, Santa Cla
November 12, 2024 Designed specifically for use in radiation oncology, new Spectral CT 7500 RT enables personalized radiation therapy planning to deliver better care for more cancer patients Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced a major advance in radiation oncology with 510(k) clearance from the US Food and Drug Administration (FDA) for its new detector-based spectral computed tomography (CT) radiotherapy solution. Philips Spectral CT 7500 RT marks the next step in personalized cancer care by integrating the unique tumor visualization and tissue characterization capabilities of spectral CT into cancer trea
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD)Cardiovascular Institute of the South successfully treats first patient in the U.S. using Philips' innovative laser system, marking a milestone in advancing personalized care for PAD patients Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced enrollment of the first patient in the U.S. THOR IDE clinical trial, which will study an innovative combined laser atherectomy and intravascular lithotripsy catheter de
Industry leaders collaborate to offer Philips clinically proven tools and resources to Aspen Dental patients, providing better care for more people CAMBRIDGE, Mass., Oct. 30, 2024 /PRNewswire/ -- Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced a partnership with Aspen Dental®, the largest group of branded dental offices, to bring Philips Sonicare, the No.1 dental professional-recommended sonic toothbrush brand worldwide, to Aspen Dental's national network of over 1,100 locations. Aspen Dental's clinicians will now be able to offer Philips Sonicare solutions in office, including Philips Sonicare ExpertClean, which uses built-in smart sensors to guid
After successful development and pilot, groundbreaking technology using biomarkers from wearables to predict infection is set to expand within the DoD Royal Philips (NYSE:PHG, AEX: PHIA)) today announced it will accelerate the predictive health monitoring of the Rapid Analysis of Threat Exposure (RATE) algorithm to support the well-being and readiness of active-duty service personnel for the U.S. Department of Defense (DoD). Over the next four years, the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), will invest $25 million to make the technology more accessible in the field. RATE, in advanced development, is an early detector of pr
October 28, 2024 Third-quarter highlights Group sales amounted to EUR 4.4 billion, with flat comparable sales growthIncome from operations was EUR 337 millionAdjusted EBITA margin increased by 160 basis points from 10.2% to 11.8% of salesOperating cashflow of EUR 192 million, with a free cashflow of EUR 22 millionComparable order intake decreased by 2%, due to decline in ChinaOutlook for full-year 2024 revised to reflect deteriorated demand in China: comparable sales growth within an updated range 0.5%-1.5%, Adjusted EBITA margin at around 11.5%, the upper end of current range; free cashflow at around EUR 0.9 billion, at lower end of current range Roy Jakobs, CEO of Royal Philips:
October 24, 2024 Both companies also join the newly established World Stroke Organization Advocacy Coalition Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA))), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke care is crucial to saving lives and reducing long-term disability. As leaders in stroke diagnosis and treatment, the two organizations are advocating on raising awareness around the potential health and economic benefits for patients, their families and societies of improving access to timely stroke diagnosis and treatmen
October 21, 2024 Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment for even the most complex procedures.The Philips Engagement Hub in Hall C at the Walter E. Washington Convention Center will feature numerous physician-led discussions, and hands-on trainings that address a range of key challenges in cardiology. Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA))), a global leader in health technology, is showcasing its latest solutions in cardiology at the Transcatheter Cardiovasc
First-ever demo of connected in-cabin vital signs monitoring will debut at AutoSens Europe, featuring OMNIVISION's state-of-the-art CMOS image sensor and Philips' vital signs camerai for automotive software OMNIVISION, a leading global developer of semiconductor solutions, including advanced digital imaging, analog and touch & display technology, and Philips, a global technology company focused on improving people's health and well-being through meaningful innovation in healthcare and consumer lifestyle, today announced they will jointly demonstrate a prototype of the world's first in-cabin connected well-being monitoring solution at AutoSens Europe, taking place October 8-10, 2024, at Pal
Jefferies upgraded Philips from Underperform to Hold
Bernstein upgraded Philips from Mkt Perform to Outperform
Exane BNP Paribas upgraded Philips from Underperform to Neutral
UBS upgraded Philips from Sell to Neutral
JP Morgan upgraded Philips from Underweight to Neutral
Exane BNP Paribas downgraded Philips from Outperform to Underperform
Goldman initiated coverage of Philips with a rating of Buy
UBS downgraded Philips from Neutral to Sell
Morgan Stanley initiated coverage of Philips with a rating of Equal-Weight
Deutsche Bank downgraded Philips from Hold to Sell
November 12, 2024 Designed specifically for use in radiation oncology, new Spectral CT 7500 RT enables personalized radiation therapy planning to deliver better care for more cancer patients Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA)), a global leader in health technology, today announced a major advance in radiation oncology with 510(k) clearance from the US Food and Drug Administration (FDA) for its new detector-based spectral computed tomography (CT) radiotherapy solution. Philips Spectral CT 7500 RT marks the next step in personalized cancer care by integrating the unique tumor visualization and tissue characterization capabilities of spectral CT into cancer trea
October 28, 2024 Third-quarter highlights Group sales amounted to EUR 4.4 billion, with flat comparable sales growthIncome from operations was EUR 337 millionAdjusted EBITA margin increased by 160 basis points from 10.2% to 11.8% of salesOperating cashflow of EUR 192 million, with a free cashflow of EUR 22 millionComparable order intake decreased by 2%, due to decline in ChinaOutlook for full-year 2024 revised to reflect deteriorated demand in China: comparable sales growth within an updated range 0.5%-1.5%, Adjusted EBITA margin at around 11.5%, the upper end of current range; free cashflow at around EUR 0.9 billion, at lower end of current range Roy Jakobs, CEO of Royal Philips:
July 29, 2024 Second-quarter highlights Group sales amounted to EUR 4.5 billion, with comparable sales growth of 2%Comparable order intake increased by 9%Income from operations EUR 816 million, including EUR 538 million insurance income*)Adjusted EBITA margin increased to 11.1% of salesOperating cash inflow of EUR 89 million, with a free cash outflow of EUR 64 million Roy Jakobs, CEO of Royal Philips:"I am encouraged by our return to order intake growth this quarter, primarily driven by North America. Within a challenging macro environment we achieved strong margin improvement, supported by our productivity program, solid operational cashflow due to improved working capital m
May 15, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA))), today announced that the exchange ratio for the dividend for the year 2023 is 1 new common share for every 29.2684 existing common shares. This ratio was based on the volume weighted average price on Euronext Amsterdam of May 9, 10 and 13, 2024, of EUR 24.8481 and was calculated in a manner that the gross dividend in shares will be approximately equal to EUR 0.85. As a result, Philips will issue a total number of 30,860,582 new common shares. Distribution of the dividend with delivery of new common shares and settlement of any fractions in cash, will take place from May 16, 2024. Upon distribution, the total i
March 22, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA))), today announced it has convened the Annual General Meeting of Shareholders (AGM) 2024 and published the agenda with explanatory notes. As previously announced, the agenda includes: Proposals to re-appoint Chairman Feike Sijbesma (Dutch, 1959) and Peter Löscher (Austrian, 1957) as members of the Supervisory Board, with effect from May 7, 2024.Proposal to appoint Charlotte Hanneman (Dutch, 1978) as member of the Board of Management, fulfilling the role of Chief Financial Officer, with effect from October 1, 202
July 24, 2023 Second-quarter highlights Group sales increased to EUR 4.5 billion, with 9% comparable sales growthIncome from operations amounted to EUR 221 million, compared to EUR 11 million in Q2 2022Adjusted EBITA increased to EUR 453 million, or 10.1% of sales, compared to EUR 216 million, or 5.2% of sales, in Q2 2022Order book continued to grow year-on-year, while comparable order intake declined following a high order intake in Q2 2022Operating cash flow improved to EUR 135 million, compared to an outflow of EUR 306 million in Q2 2022Simplification of the operating model and restructuring plans on trackOutlook for full year 2023 raised to mid-single-di
May 17, 2023Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA))) today announced that the exchange ratio for the dividend for the year 2022 is 1 new common share for every 22.3906 existing common shares. This ratio was based on the volume weighted average price on Euronext Amsterdam of May 11, 12 and 15, 2023, of EUR 19.0020 and was calculated in a manner that the gross dividend in shares will be approximately equal to EUR 0.85. As a result, Philips will issue a total number of 39,334,938 new common shares. Distribution of the dividend with delivery of new common shares and settlement of any fractions in cash, will take place from May 18, 2023. Upon distribution, the total iss
May 9, 2023 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA))) announced that today's Annual General Meeting of Shareholders (2023 AGM) has reappointed Abhijit Bhattacharya for a two year's term as member of the Board of Management fulfilling the role of CFO, and reappointed Liz Doherty and David Pyott as members of the Supervisory Board. With these reappointments, the composition of the Supervisory Board committees remains unchanged. Other voting items, such the company's proposed dividend of EUR 0.85 per share over 2022, [1] the proposal to reappoint EY as the company's external auditor for a term of one year starting January 1, 2024, and the proposal to appoint Pr
March 24, 2023 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA))) today announced it has convened the Annual General Meeting of Shareholders (AGM) 2023 and published the agenda with explanatory notes. The agenda of the AGM 2023 includes the recommendation of the Supervisory Board, endorsed by Philips' Chief Executive Officer to the shareholders to re-appoint Abhijit Bhattacharya (Indian, 1961) as member of the Board of Management for an additional period of two years, with effect from May 9, 2023. Mr Bhattacharya has held the positions of Chief Financial Officer and member of the Board of Management since 2015. Additionally, it will be proposed to the sharehol
January 30, 2023 Fourth-quarter highlights Group sales amounted to EUR 5.4 billion, with 3% comparable sales growth driven by component supply improvements, while Philips' supply chain conditions remain challengingComparable order intake decreased 8%, due to lower demand for COVID-19-related products compared to 2021 and company actions to improve the order book margin profileIncome from operations amounted to EUR 171 million, compared to EUR 162 million in Q4 2021Adjusted EBITA of EUR 651 million, or 12.0% of sales, compared to EUR 647 million, or 13.1% of sales, in Q4 2021Operating cash flow was EUR 540 million, compared to EUR 720 million in Q4 2021 Full-year hi
July 3, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA))), a global leader in health technology, today announced the appointment of Ms Ling Liu as the Chief Region Leader of Philips Greater China, effective immediately. Ms Liu is now a member of Philips' Executive Committee, reporting to Philips CEO Roy Jakobs. She succeeds Andy Ho, who has decided to retire after a long and successful career. Ms Liu and Mr Ho continue to work together to ensure a smooth handover. "Ling is a talented, trusted leader and I am delighted that she will join Philips' Executive Committee as the Chief Region Leader of Philips Greater China," said Roy Jakobs, CEO of Royal Philips. "Sh
May 7, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA))), today announced that its shareholders approved all proposals at the Annual General Meeting of Shareholders (AGM) 2024, including: The re-appointment of Chairman Feike Sijbesma and Peter Löscher as members of the Supervisory Board.The appointment of Benoît Ribadeau-Dumas as member of the Supervisory Board.The appointment of Charlotte Hanneman as member of the Board of Management, with effect from October 1, 2024.The discharge of the members of the Board of Management and members of the Supervisory Board.A full overview of the resolutions taken at the AGM 2024 can be found below.
February 28, 2024 Proposal to appoint Ms. Hanneman as member of Philips' Board of Management fulfilling the role of CFO per October 1, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA))), a global leader in health technology, today announced the proposal to appoint Charlotte Hanneman as member of the Board of Management, fulfilling the role of Chief Financial Officer (CFO), effective October 1, 2024. The proposal will be submitted to the Annual General Meeting of Shareholders (AGM), to be held on May 7, 2024. Ms. Hanneman will join Philips as a member of Philips' Executive Committee on June 1, 2024, to start her induction and transition into the
SAN FRANCISCO, May 02, 2023 (GLOBE NEWSWIRE) -- Via Licensing Alliance LLC (Via LA), the collaborative licensing leader, announced today the appointment of three new members to its Board of Directors: Patrick Patnode, President of GE Licensing, an affiliate of General Electric Company (NYSE:GE); Jako Eleveld, Vice President and Head of IP Licensing at Koninklijke Philips N.V. (NYSE:PHG); and Keiko Higuchi, Senior Manager and Head of Patent Pools in the Corporate Licensing Division of the Mitsubishi Electric Corporation (TSE: 6503). Their appointment follows the conversion of partial ownership in MPEG LA to an ownership stake in Via LA by affiliates of GE, Philips, and Mitsubishi Electric i
March 13, 2023 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA))), a global leader in health technology, today announced the appointment of Julia Strandberg as the Chief Business Leader of its Connected Care businesses, effective April 24, 2023. Ms. Strandberg will become a member of Philips' Executive Committee reporting to Philips CEO Roy Jakobs. As of April 1, 2023, Philips' Connected Care businesses will comprise the Monitoring, Sleep & Respiratory Care and Enterprise Informatics businesses. Ms. Strandberg (American, 1974) joins Philips from Pear Therapeutics, where she served as the Chief Commercial Officer leading the commercial team that built, launched and
June 7, 2022 Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA))), a global leader in health technology, today announced that Willem (Wim) Appelo will join Philips' Executive Committee, effective July 18, 2022, and succeed Sophie Bechu as Chief Operations Officer per October 1, 2022. Mr. Appelo will report to Philips CEO Frans van Houten and work closely with Mrs. Bechu to ensure a seamless transition. Mrs. Bechu, who joined Philips in 2016, will step down from her role on October 1, 2022, after which she will work on project-based initiatives until she retires at the end of January, 2023. Mr. Appelo (Dutch, 1964) will join Philips after having worked as interim Supply Chain
May 10, 2022 Philips' Supervisory Board takes note of the advisory vote on the 2021 Remuneration Report, will continue to engage with shareholders and consider the feedback received in its next remuneration report Amsterdam, the Netherlands – Royal Philips (NYSE:PHG, AEX: PHIA))) announced that today's Annual General Meeting of Shareholders (2022 AGM) has approved the company's proposed dividend of EUR 0.85 per share over 2021, and appointed Mrs. Herna Verhagen and Mr. Sanjay Poonen and re-appointed Dr. Paul Stoffels and Dr. Marc Harrison as members of the Supervisory Board. All other binding voting items, such as the re-appointment of Ernst & Young Accountants LLP as the company's audito
MINNEAPOLIS, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical") (NASDAQ:TCMD), a medical technology company focused on developing medical devices for the treatment of patients with underserved chronic diseases at home, today announced the appointment of Valerie L. Asbury and D. Brent Shafer to the Company's Board of Directors ("Board"), effective January 5, 2022. Ms. Asbury will serve as a member of both the Audit Committee and the Compliance & Reimbursement Committee. Mr. Shafer will serve as a member of the Audit Committee, the Compensation & Organization Committee, and the Nominating & Corporate Governance Committee. Three long-standing directors will
MINNEAPOLIS, April 20, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical") (NASDAQ:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced the appointment of Eric Pauls to the position of Senior Vice President of Sales, effective May 1, 2021. Mr. Pauls will succeed Bryan Rishe, who is retiring in May. "Eric is a strategic leader with over 20 years of experience in the healthcare industry and a proven history of building scale and leading high-performance teams," said Dan Reuvers, President and Chief Executive Officer of Tactile Medical. "His career has been dedicated to establishin
February 23, 2021 Current Chairman Jeroen van der Veer and Vice-Chairwoman Mrs. Christine Poon to retire from Philips’ Supervisory Board after their third consecutive term, effective upon closing of the 2021 Annual General Meeting of ShareholdersMrs. Orit Gadiesh, Philips’ Supervisory Board member since 2014, to step down Philips’ Supervisory Board appoints Feike Sijbesma as its Chairman and Paul Stoffels as its Vice-ChairmanMrs. Chua Sock Koong and Mrs. Indra Nooyi to be proposed as new members of the Supervisory BoardPhilips Chief Legal Officer Marnix van Ginneken proposed for reappointment as a member of Philips’ Board of Management Amsterdam, the Netherlands – Royal Philips (NYSE: PH